story of the week
Switching From Natalizumab to Ocrelizumab in Patients With Multiple Sclerosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Switching From Natalizumab to Ocrelizumab in Patients With Multiple Sclerosis
Mult. Scler. 2020 Jun 19;[EPub Ahead of Print], SN Levin, C Ezuma, L Levine, WS Vargas, RS Farber, PL De Jager, CS RileyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.